Completed

Phase 2
Age: 3Months - 6Years
All Genders
ID00000789

A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection

Led by National Institute of Allergy and Infectious Diseases (NIAID) · Updated on 2021-11-04

230

Participants Needed

54

Research Sites

N/A

Total Duration

On this page

Sponsors

N

National Institute of Allergy and Infectious Diseases (NIAID)

Lead Sponsor

G

Glaxo Wellcome

Collaborating Sponsor

AI-Summary

What this Trial Is About

PRIMARY: To compare the relative safety and tolerance of oral zidovudine (AZT) versus oral stavudine (d4T) in symptomatic HIV-infected children. SECONDARY: To compare the clinical, virologic, and immunologic responses between the two treatment groups, and to obtain pharmacokinetic data for both drugs. At present, AZT is considered the drug of choice for initial treatment of most children with HIV infection, although disease progression or drug intolerance is associated with its long-term use. In preliminary studies in children, d4T, another HIV inhibitor, has been well tolerated, although an optimum dose has not been determined.

CONDITIONS

Official Title

A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection

Who Can Participate

Age: 3Months - 6Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

Inclusion Criteria

Concurrent Medication:

Recommended:

  • PCP prophylaxis.

Allowed:

  • Immunoglobulin.
  • Erythropoietin, G-CSF, and GM-CSF.
  • Corticosteroids.
  • Ethionamide or isoniazid for TB if no alternative is available.
  • Pyridoxine (up to 50 mg/day) as vitamin supplement.

Patients must have:

  • Symptomatic HIV infection.
  • No more than 6 weeks of prior antiretroviral or immunomodulator therapy (other than steroids and IVIG).
  • Consent of parent or guardian.

NOTE:

  • Coenrollment on another ACTG protocol not involving antiretroviral therapy is permitted.

Prior Medication:

Allowed:

  • Maternal immunomodulator or antiretroviral therapy (including during pregnancy).
  • Antiretroviral therapy prior to 2 months.
  • Up to 6 weeks of prior antiretroviral therapy or specific immunomodulator therapy (other than corticosteroids and IVIG).

Exclusion Criteria

Co-existing Condition:

Patients with the following symptoms or conditions are excluded:

  • Current grade 3 or worse neuropathy / lower motor neuropathy.
  • Other grade 3 or worse clinical or laboratory toxicities.
  • Known intolerance to either AZT or d4T.

Concurrent Medication:

Excluded:

  • Chemotherapy for active malignancy.

Patients with the following prior conditions are excluded:

  • History of grade 3 or worse neuropathy/lower motor neuropathy.

Prior Medication:

Excluded:

  • More than 6 weeks of prior antiretroviral or immunomodulator therapy.
  • Antiretroviral or immunomodulator therapy within 7 days prior to study entry. Ongoing drug or alcohol abuse.
Not Eligible

You will not qualify if you...

History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety

Trial Site Locations

Total: 54 locations

1

Long Beach Memorial Med. Ctr., Miller Children's Hosp.

Long Beach, California, United States, 90801

Status Unknown

2

Usc La Nichd Crs

Los Angeles, California, United States, 90033

Status Unknown

3

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS

Los Angeles, California, United States, 90095

Status Unknown

4

Children's Hosp. & Research Ctr. Oakland, Ped. Clinical Research Ctr. & Research Lab.

Oakland, California, United States, 94609

Status Unknown

5

UCSD Maternal, Child, and Adolescent HIV CRS

San Diego, California, United States, 92093

Status Unknown

6

UCSF Pediatric AIDS CRS

San Francisco, California, United States, 94143

Status Unknown

7

Harbor - UCLA Med. Ctr. - Dept. of Peds., Div. of Infectious Diseases

Torrance, California, United States, 90502

Status Unknown

8

Univ. of Colorado Denver NICHD CRS

Aurora, Colorado, United States, 80218

Status Unknown

9

Univ. of Connecticut Health Ctr., Dept. of Ped.

Farmington, Connecticut, United States, 06032

Status Unknown

10

Yale Univ. School of Medicine - Dept. of Peds., Div. of Infectious Disease

New Haven, Connecticut, United States, 06504

Status Unknown

11

Children's National Med. Ctr., ACTU

Washington D.C., District of Columbia, United States, 20010

Status Unknown

12

Howard Univ. Washington DC NICHD CRS

Washington D.C., District of Columbia, United States, 20060

Status Unknown

13

Univ. of Florida Jacksonville NICHD CRS

Jacksonville, Florida, United States, 32209

Status Unknown

14

Univ. of Miami Ped. Perinatal HIV/AIDS CRS

Miami, Florida, United States, 33161

Status Unknown

15

Emory Univ. School of Medicine, Dept. of Peds., Div. of Infectious Diseases

Atlanta, Georgia, United States, 30306

Status Unknown

16

Cook County Hosp.

Chicago, Illinois, United States, 60612

Status Unknown

17

Univ. of Illinois College of Medicine at Chicago, Dept. of Peds.

Chicago, Illinois, United States, 60612

Status Unknown

18

Chicago Children's CRS

Chicago, Illinois, United States, 60614

Status Unknown

19

Univ. of Chicago - Dept. of Peds., Div. of Infectious Disease

Chicago, Illinois, United States, 60637

Status Unknown

20

Tulane/LSU Maternal/Child CRS

New Orleans, Louisiana, United States, 70112

Status Unknown

21

Univ. of Maryland Med. Ctr., Div. of Ped. Immunology & Rheumatology

Baltimore, Maryland, United States, 21201

Status Unknown

22

HMS - Children's Hosp. Boston, Div. of Infectious Diseases

Boston, Massachusetts, United States, 02115

Status Unknown

23

BMC, Div. of Ped Infectious Diseases

Boston, Massachusetts, United States, 02118

Status Unknown

24

Baystate Health, Baystate Med. Ctr.

Springfield, Massachusetts, United States, 01199

Status Unknown

25

WNE Maternal Pediatric Adolescent AIDS CRS

Worcester, Massachusetts, United States, 01655

Status Unknown

26

Children's Hospital of Michigan NICHD CRS

Detroit, Michigan, United States, 48201

Status Unknown

27

Cooper Univ. Hosp.

Camden, New Jersey, United States, 08103

Status Unknown

28

UMDNJ - Robert Wood Johnson

New Brunswick, New Jersey, United States, 08903

Status Unknown

29

St. Joseph's Hosp. & Med. Ctr. of New Jersey

Paterson, New Jersey, United States

Status Unknown

30

Children's Hospital at Albany Medical Center, Dept. of Peds.

Albany, New York, United States, 12208

Status Unknown

31

SUNY Downstate Med. Ctr., Children's Hosp. at Downstate NICHD CRS

Brooklyn, New York, United States, 11203

Status Unknown

32

North Shore-Long Island Jewish Health System, Dept. of Peds.

Great Neck, New York, United States, 11021

Status Unknown

33

Schneider Children's Hosp., Div. of Infectious Diseases

New Hyde Park, New York, United States, 11040

Status Unknown

34

NYU Med. Ctr., Dept. of Medicine

New York, New York, United States, 10016

Status Unknown

35

Metropolitan Hosp. NICHD CRS

New York, New York, United States, 10029

Status Unknown

36

Columbia IMPAACT CRS

New York, New York, United States, 10032

Status Unknown

37

Incarnation Children's Ctr.

New York, New York, United States, 10032

Status Unknown

38

Harlem Hosp. Ctr. NY NICHD CRS

New York, New York, United States, 10037

Status Unknown

39

Univ. of Rochester ACTG CRS

Rochester, New York, United States, 14642

Status Unknown

40

SUNY Stony Brook NICHD CRS

Stony Brook, New York, United States, 11794

Status Unknown

41

SUNY Upstate Med. Univ., Dept. of Peds.

Syracuse, New York, United States, 13210

Status Unknown

42

Bronx-Lebanon Hosp. IMPAACT CRS

The Bronx, New York, United States, 10457

Status Unknown

43

UNC at Chapel Hill School of Medicine - Dept. of Peds., Div. of Immunology & Infectious Diseases

Chapel Hill, North Carolina, United States

Status Unknown

44

DUMC Ped. CRS

Durham, North Carolina, United States, 27710

Status Unknown

45

The Children's Hosp. of Philadelphia IMPAACT CRS

Philadelphia, Pennsylvania, United States, 19104

Status Unknown

46

St. Christopher's Hosp. for Children

Philadelphia, Pennsylvania, United States, 19134

Status Unknown

47

Med. Univ. of South Carolina, Div. of Ped. Infectious Diseases

Charleston, South Carolina, United States, 29425

Status Unknown

48

St. Jude/UTHSC CRS

Memphis, Tennessee, United States, 38105

Status Unknown

49

Children's Med. Ctr. Dallas

Dallas, Texas, United States, 75235

Status Unknown

50

Texas Children's Hosp. CRS

Houston, Texas, United States, 77030

Status Unknown

51

UW School of Medicine - CHRMC

Seattle, Washington, United States, 98105

Status Unknown

52

Univ. Hosp. Ramón Ruiz Arnau, Dept. of Peds.

Bayamón, Puerto Rico, 00956

Status Unknown

53

San Juan City Hosp. PR NICHD CRS

San Juan, Puerto Rico, 00936

Status Unknown

54

Univ. of Puerto Rico Ped. HIV/AIDS Research Program CRS

San Juan, Puerto Rico, 00936

Status Unknown

Loading map...

How is the study designed?

Study Type

INTERVENTIONAL

Masking

N/A

Allocation

N/A

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Combination therapy with stavudine and didanosine in children with advanced human immunodeficiency virus infection: pharmacokinetic properties, safety, and immunologic and virologic effects.

M W Kline, C V Fletcher, M E Federici...

https://pubmed.ncbi.nlm.nih.gov/8657531

A randomized comparative trial of stavudine (d4T) versus zidovudine (ZDV, AZT) in children with human immunodeficiency virus infection. AIDS Clinical Trials Group 240 Team.

M W Kline, R B Van Dyke, J C Lindsey...

https://pubmed.ncbi.nlm.nih.gov/9445494
A Randomized, Comparative Trial of Zidovudine (AZT) Versus 2',3'-Didehydro-3'-Deoxythymidine (Stavudine; d4T) in Children With HIV Infection | DecenTrialz